Cancer remains the leading cause of death around the world. In cancer treatment, over 50%
of cancer patients receive radiotherapy alone or in multimodal combinations with other …

Despite revolutionizing the field of oncological imaging, Positron Emission Tomography
(PET) with [18F] Fluorodeoxyglucose (FDG) as its workhorse is limited by a lack of specificity …

No effective treatment of systemic sclerosis-associated interstitial lung disease (SSc-ILD)
exists. Numerous evidences support the importance of adaptive immunity in SSc-ILD. A …

Rationale: Sustained activation of lung fibroblasts and the resulting oversynthesis of the
extracellular matrix are detrimental events for patients with interstitial lung diseases (ILDs) …

An increasing number of patients worldwide suffers from chronic kidney disease (CKD).
CKD is accompanied by kidney fibrosis, which affects all compartments of the kidney, ie, the …

Myocardial fibrosis is the heart's common healing response to injury. While initially seeking
to optimize the strength of diseased tissue, fibrosis can become maladaptive, producing stiff …

Purpose Myocardial fibrosis (MF) is a factor of poor prognosis in systemic sclerosis (SSc).
Direct in-vivo visualization of fibroblast activation as early readout of MF has not been …

Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease resulting in irreversible scarring
within the lungs. However, the lack of biomarkers that enable real-time assessment of …

Idiopathic pulmonary fibrosis (IPF) is a chronic fibrosing interstitial lung disease with a poor
prognosis. 68Ga-labeled FAP ligands exhibited highly promising results due to the crucial …

Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial disease that cannot be cured, and
treatment options for IPF are very limited. Early diagnosis, close monitoring of disease …